Bendamustine for the first-line treatment of chronic lymphocytic leukaemia

NICE technology appraisals [TA216] Published date:

NICE recommends bendamustine as a possible treatment for some people with chronic lymphocytic leukaemia of Binet stage B or C

Who can have bendamustine?

You should be able to have bendamustine if:

  • you have chronic lymphocytic leukaemia of Binet stage B or C that has not been treated before and
  • you cannot have chemotherapy with a drug called fludarabine.

Get involved